Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid effects on lymphocyte subpopulations in primary osteoporosis
ChiCTR1900021796Phase 4Recruiting
- Sponsor
- Central Hospital Affiliated to Shandong First Medical University
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zoledronic acid in involutional osteoporosis, sponsored by Central Hospital Affiliated to Shandong First Medical University. Primary endpoints: lymphocyte subpopulations, bone mineral density and 3 more. Started Jan 2015; status: recruiting.
02
Drugs
zoledronic acid
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on ChiCTR1900021796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021796.